Inova Health System:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Inova Health System - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5147
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inova Health System (Inova) is a non-profit health care system operating through multiple hospitals. It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others. Through a network of hospitals including Inova Alexandria Hospital, Inova Fair Oaks Hospital, Inova Fairfax Hospital, Inova Loudoun Hospital, and Inova Mount Vernon Hospital the organization provides inpatient services and outpatient health services including emergency and urgent care, senior services, home care, mental health and blood donor services. Its other healthcare facilities include Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) which focuses on genomics research, Inova Neuroscience Institute and Inova Children’s Hospital. Inova is headquartered in Falls Church, Virginia, the US.

Inova Health System – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inova Health System, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Inova Health System Enters into Research Agreement with George Mason University 11
Debt Offering 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For US$1.7 Million 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For US$85.1 Million 13
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For US$3.3 Million 14
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For US$3.4 Million 15
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For US$1.9 Million 16
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For US$35 Million 17
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For US$4.1 Million 18
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For US$2.6 Million 19
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$2 Million 20
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For US$3.3 Million 21
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For US$4.4 Million 22
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$33 Million 23
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For US$2.9 Million 24
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For US$4.3 Million 25
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For US$4.5 Million 26
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For US$2.7 Million 27
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$25 Million 28
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For US$5.2 Million 29
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For US$3.4 Million 30
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For US$3.3 Million 31
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For US$4 Million 32
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For US$15 Million 33
Acquisition 34
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34
Inova Health System – Key Competitors 35
Inova Health System – Key Employees 36
Inova Health System – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 39
Corporate Communications 39
Mar 14, 2018: Inova Board Names J. Stephen Jones as New Chief Executive Officer 39
Oct 18, 2017: The Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors 40
Sep 15, 2017: Inova CEO Knox Singleton Announces Retirement 41
Sep 06, 2017: Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization 42
Government and Public Interest 43
May 18, 2018: President George W. Bush Headlines Record-Breaking Fundraiser for Inova Schar Cancer Institute 43
Other Significant Developments 44
Feb 23, 2018: Inova Loudoun Hospital Mobile Health Services March 2018 Screenings Schedule 44
Feb 19, 2018: Inova Loudoun Hospital Offering New Hope And Insights 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Inova Health System, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9
Inova Health System, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Inova Health System Enters into Research Agreement with George Mason University 11
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2027 For US$1.7 Million 12
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2040 For US$85.1 Million 13
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2020 For US$3.3 Million 14
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2019 For US$3.4 Million 15
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2026 For US$1.9 Million 16
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2037 For US$35 Million 17
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2013 For US$4.1 Million 18
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2025 For US$2.6 Million 19
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$2 Million 20
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2021 For US$3.3 Million 21
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2016 For US$4.4 Million 22
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$33 Million 23
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2023 For US$2.9 Million 24
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2015 For US$4.3 Million 25
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2017 For US$4.5 Million 26
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2024 For US$2.7 Million 27
Inova Health System Completes Public Offering Of Series 2012B Bonds Due 2022 For US$25 Million 28
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2032 For US$5.2 Million 29
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2018 For US$3.4 Million 30
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2022 For US$3.3 Million 31
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2014 For US$4 Million 32
Inova Health System Completes Public Offering Of Series 2012A Bonds Due 2035 For US$15 Million 33
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 34
Inova Health System, Key Competitors 35
Inova Health System, Key Employees 36
Inova Health System, Other Locations 37
Inova Health System, Subsidiaries 38

List of Figures
Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Inova Health System, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Inova Health System, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Inova Health System, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Inova Health System, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Inova Health System:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellumed Co Ltd (049180)-医療機器分野:企業M&A・提携分析
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc, is a biotechnology company that develops bone graft substitution based on human tissue graft. The company’s portfolio encompasses spinal fixation systems; joint replacement and navigation system; bone powder; DBM gel; bio-clearant, an …
  • Global Foundries Inc:企業のM&A・事業提携・投資動向
    Global Foundries Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Global Foundries Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析
    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telecom Argentina S.A.:企業の戦略・SWOT・財務情報
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TIBCO Software, Inc.:企業のM&A・事業提携・投資動向
    TIBCO Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TIBCO Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • China CAMC Engineering Co Ltd (002051):企業の財務・戦略的SWOT分析
    Summary China CAMC Engineering Co Ltd (CAMC), a subsidiary of China National Machinery Industry Corp, is a construction company that offers engineering, procurement and construction services. The company designs and constructs shipyard, turnkey project in pulp plant, agricultural equipment industria …
  • Philippine Long Distance Telephone Company:企業のM&A・事業提携・投資動向
    Philippine Long Distance Telephone Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Philippine Long Distance Telephone Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析
    Summary Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases tha …
  • BSN medical GmbH:医療機器:M&Aディール及び事業提携情報
    Summary BSN medical GmbH (BSN medical), a subsidiary of Essity Aktiebolag, is healthcare company specialized in compression therapy, wound care and othropedics. It manufactures and markets medical products for wound care and related vascular diseases and lumphology, and non-invasive orthopedic produ …
  • Univar Solutions Inc (UNVR):企業の財務・戦略的SWOT分析
    Univar Solutions Inc (UNVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Bank of Scotland Plc:企業のM&A・事業提携・投資動向
    Bank of Scotland Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bank of Scotland Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Ramaco Resources Inc. (METC):企業の財務・戦略的SWOT分析
    Ramaco Resources Inc. (METC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • IBIDEN CO., LTD.:戦略・SWOT・企業財務分析
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Glythera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Glythera Ltd (Glythera) is a biotechnology company that focuses on the development of antibody drug conjugates (ADCs) and biotherapeutics for the treatment of cancer. The company develops antibody-based therapies for the treatment of cancer and broader based therapeutics. It uses its proprie …
  • Entergy Corporation (ETR):企業の財務・戦略的SWOT分析
    Entergy Corporation (ETR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Arena Pharmaceuticals Inc (ARNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. It is evaluating its lead candidate etrasimod for multiple inflammatory indications including ulcerative colitis, primary biliary chol …
  • Greenhill & Co Inc:企業の戦略・SWOT・財務情報
    Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report Summary Greenhill & Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Novita Healthcare Ltd (NHL):製薬・医療:M&Aディール及び事業提携情報
    Summary Novita Healthcare Ltd (Novita Healthcare), formerly Avexa Ltd is a medical technology company that focuses on the measurement and treatment of attention difficulties in early childhood. The company operates through its subsidiary The Tali technology, which is developing a tablet based softwa …
  • Ajman Bank (AJMANBANK):企業の財務・戦略的SWOT分析
    Ajman Bank (AJMANBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆